Medico Research Chronicles https://medrech.com/index.php/medrech <p style="text-align: justify;"><code></code><strong>Medico Research Chronicles (Medrech) ISSN No. 2394-3971</strong>, as the official journal of Medico Edge Publications, serves as a catalyst for advancing medical and health sciences. With its commitment to excellence, the journal invites diverse manuscripts that contribute to the ever-evolving landscape of medical, health science, and clinical research. Through its rigorous peer review process, open-access policy, and timely publication, Medico Research Chronicles continues to be a trusted platform for researchers and practitioners, driving innovation and shaping the future of healthcare.</p> <p>Indexed by the&nbsp;&nbsp;<a href="https://www.ncbi.nlm.nih.gov/nlmcatalog/?term=Medico+Research+chronicles"><strong>United States'&nbsp;NLM Catalogue, NCBI</strong></a></p> <p><strong><a href="https://journals.indexcopernicus.com/search/details?id=31567&amp;lang=pl">Index Copernicus</a>, </strong>Medico Research Chronicles, the esteemed journal of Medico Edge Publications, has received a positive evaluation from Index Copernicus, Poland for the year 2021. With an impressive IC Value of 84.43, the journal reaffirms its position as a reputable platform for groundbreaking research in the field of medical and health sciences. This recognition underscores the journal's commitment to scientific excellence and its significant contribution to advancing healthcare knowledge. Researchers and practitioners can rely on Medico Research Chronicles as a trusted source of innovative research findings.</p> <p><strong>Academicians and Researchers interested in reviewing the article are requested to join us on Publons: <a title="Publons by Web of Science" href="https://publons.com/journal/102220/medico-research-chronicles/">https://publons.com/journal/102220/medico-research-chronicles/</a></strong></p> <p><strong><a href="https://www.nmc.org.in/e-gazette">Click Here </a></strong>for the notification details.</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p> en-US editor@medrech.com (Dr. Bindu Jain) info@medrech.com (Dr. Vibhor Kumar Jain) Thu, 18 Apr 2024 11:05:51 +0530 OJS 3.1.2.4 http://blogs.law.harvard.edu/tech/rss 60 Effect of Maternal Pre-eclampsia and eclampsia on Serum Electrolytes of Newborns in a rural tertiary care hospital in western Maharashtra https://medrech.com/index.php/medrech/article/view/699 <p><strong>A</strong><strong>ims and objectives</strong>: To study the serum electrolytes of neonates born to pre-eclampsia and eclampsia mothers in rural tertiary care hospital.</p> <p><strong>Materials and methods: </strong>This hospital-based descriptive cross-sectional study, conducted at Dr. Vitthalrao Vikhe Patil Pravara Rural Hospital over a year from September 2022 to September 2023, focused on neonates born to mothers with pre-eclampsia and eclampsia. Excluded were babies with congenital malformations and those born to mothers with other health issues.</p> <p>&nbsp;<strong>Results: </strong>Three fourth of the PIH mothers in our study were pre-eclampsia while one fourth were eclampsia. In the present study 65% babies were preterm , 34% babies were more than 37 weeks. In pre-eclampsia mean value of magnesium was 2.9 ±0.72. In eclampsia mean value of magnesium was 4.17 ±1.38. There is highly statistically significant difference between pre-eclampsia and eclampsia.</p> <p><strong>Conclusion: </strong>Babies delivered to hypertensive mothers are more likely to experience a variety of difficulties, it is important to closely monitor</p> <p>these infants in an effort to reduce morbidity and promote better growth, development, and survival.</p> Lakhan Khurana, Jayashree P Jadhav, P.V. Nigwekar Copyright (c) 2024 Lakhan Khurana, Jayashree P Jadhav, P.V. Nigwekar https://medrech.com/index.php/medrech/article/view/699 Thu, 18 Apr 2024 00:00:00 +0530 A Study of Maternal Risk Factors and Investigative Profile in Neonatal Polycythemia in a rural tertiary care hospital in western Maharashtra https://medrech.com/index.php/medrech/article/view/700 <p><strong>A</strong><strong>ims and objectives</strong>: To Study the Maternal Risk Factors and Investigative Profile in Neonatal Polycythemia.</p> <p><strong>Materials and methods: </strong>This is hospital based descriptive longitudinal prospective study in Dr. Vitthalrao Vikhe Patil Pravara Rural Hospital, Loni. It was carried out over a period of 1 year that is from September 2022 to September 2023. All neonates with venous hematocrit &gt;65% or venous hemoglobin concentration of more than 22g/dl were included in study. Neonates with venous hematocrit &lt;65% and Neonates with dehydration are excluded from the study.</p> <p><strong>Results</strong>: The most common maternal risk factor observed was PIH(52.3%) followed by GDM(19.7%), Multiple pregnancy(5.8%) and APH(4.6%). In the present study, we observed that most of the symptomatic babies presented with Hypoglycemia(82%), 75% babies presented with Jaundice.</p> <p><strong>Conclusion: </strong>So, babies with maternal risk factors like Hypertension, Diabetes, APH and Multiple Pregnancy should be actively screened. As most common laboratory anomaly is hypoglycemia in polycythemia babies it is important to closely monitor these infants in an effort to reduce morbidity and promote better growth, development, and survival.</p> Gowrisetty Keerthana, Dr. MRS. Bora B.D., Jayashree P Jadhav Copyright (c) 2024 Gowrisetty Keerthana, Dr. MRS. Bora B.D., Jayashree P Jadhav https://medrech.com/index.php/medrech/article/view/700 Sun, 28 Apr 2024 12:05:11 +0530